Literature DB >> 25526824

Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model.

Daniel S Quintana1, Gail A Alvares2, Ian B Hickie2, Adam J Guastella2.   

Abstract

Accumulating evidence demonstrates the important role of oxytocin (OT) in the modulation of social cognition and behavior. This has led many to suggest that the intranasal administration of OT may benefit psychiatric disorders characterized by social dysfunction, such as autism spectrum disorders and schizophrenia. Here, we review nasal anatomy and OT pathways to central and peripheral destinations, along with the impact of OT delivery to these destinations on social behavior and cognition. The primary goal of this review is to describe how these identified pathways may contribute to mechanisms of OT action on social cognition and behavior (that is, modulation of social information processing, anxiolytic effects, increases in approach-behaviors). We propose a two-level model involving three pathways to account for responses observed in both social cognition and behavior after intranasal OT administration and suggest avenues for future research to advance this research field.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Intranasal administration; Oxytocin; Social behavior; Social cognition

Mesh:

Substances:

Year:  2014        PMID: 25526824     DOI: 10.1016/j.neubiorev.2014.12.011

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  49 in total

1.  Chronic oxytocin-driven alternative splicing of Crfr2α induces anxiety.

Authors:  Erwin H van den Burg; Benjamin Jurek; Inga D Neumann; Julia Winter; Magdalena Meyer; Ilona Berger; Melanie Royer; Marta Bianchi; Kerstin Kuffner; Sebastian Peters; Simone Stang; Dominik Langgartner; Finn Hartmann; Anna K Schmidtner; Stefan O Reber; Oliver J Bosch; Anna Bludau; David A Slattery
Journal:  Mol Psychiatry       Date:  2021-05-25       Impact factor: 15.992

Review 2.  The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.

Authors:  D S Quintana; A J Guastella; L T Westlye; O A Andreassen
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992

3.  Oxytocin delivered nasally or intraperitoneally reaches the brain and plasma of normal and oxytocin knockout mice.

Authors:  Adam S Smith; Austin C Korgan; W Scott Young
Journal:  Pharmacol Res       Date:  2019-06-22       Impact factor: 7.658

4.  Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial.

Authors:  Hidenori Yamasue; Takashi Okada; Toshio Munesue; Miho Kuroda; Toru Fujioka; Yota Uno; Kaori Matsumoto; Hitoshi Kuwabara; Daisuke Mori; Yuko Okamoto; Yuko Yoshimura; Yuki Kawakubo; Yuko Arioka; Masaki Kojima; Teruko Yuhi; Keiho Owada; Walid Yassin; Itaru Kushima; Seico Benner; Nanayo Ogawa; Yosuke Eriguchi; Naoko Kawano; Yukari Uemura; Maeri Yamamoto; Yukiko Kano; Kiyoto Kasai; Haruhiro Higashida; Norio Ozaki; Hirotaka Kosaka
Journal:  Mol Psychiatry       Date:  2018-06-29       Impact factor: 15.992

5.  Selective localization of oxytocin receptors and vasopressin 1a receptors in the human brainstem.

Authors:  Sara M Freeman; Aaron L Smith; Mark M Goodman; Karen L Bales
Journal:  Soc Neurosci       Date:  2016-03-10       Impact factor: 2.083

Review 6.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

Review 7.  Oxytocin and Anxiety Disorders: Translational and Therapeutic Aspects.

Authors:  Wadih Jean Naja; Michaelangelo Pietro Aoun
Journal:  Curr Psychiatry Rep       Date:  2017-08-15       Impact factor: 5.285

8.  Localization of oxytocin receptors in the prairie vole (Microtus ochrogaster) neocortex.

Authors:  Auriane Duchemin; Adele M H Seelke; Trenton C Simmons; Sara M Freeman; Karen L Bales
Journal:  Neuroscience       Date:  2017-02-15       Impact factor: 3.590

9.  Chronic oxytocin administration as a tool for investigation and treatment: A cross-disciplinary systematic review.

Authors:  Marilyn Horta; Kathryn Kaylor; David Feifel; Natalie C Ebner
Journal:  Neurosci Biobehav Rev       Date:  2019-10-21       Impact factor: 8.989

Review 10.  A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research.

Authors:  Marilena M DeMayo; Yun Ju C Song; Ian B Hickie; Adam J Guastella
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.